The Kaplan-Meier event rate for the primary end point at @ years was @ % in the simvastatin-ezetimibe group , as compared with @ % in the simvastatin-monotherapy group ( absolute risk difference , @ percentage points ; hazard ratio , @ ; @ % confidence interval , @ to @ ; P = @ ) .